Hematology/Oncology And Stem Cell Therapy impact factor, indexing, ranking (2024)


Hematology/Oncology

Aim and Scope

The Hematology/Oncology And Stem Cell Therapy is a research journal published by the Elsevier Ltd. The P-ISSN of this journal is 16583876.

Also, please check the following important details about Hematology/Oncology and Stem Cell Therapy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.


Important Metrics

Journal Title: Hematology/Oncology and Stem Cell Therapy
Publisher: Elsevier Ltd
P-ISSN: 16583876
Open Access:
Status: Active
Scopus Coverage: 2008-ongoing

Hematology/Oncology and Stem Cell Therapy Indexing

The Hematology/Oncology and Stem Cell Therapy is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Hematology/Oncology And Stem Cell Therapy?

If your research is related to the scope of the journal, then visit the official website of Hematology/Oncology and Stem Cell Therapy and send your manuscript.

Tips for publishing in Hematology/Oncology And Stem Cell Therapy:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • It is published by Elsevier Ltd.
  • The journal is indexed in , Scopus.

Sources: Hematology/Oncology and Stem Cell Therapy







Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.